Gabrielle Sulzberger Cerevel Therapeutics Holdings, Inc. (CERE) insider trading activity

Gabrielle Sulzberger is of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of CERE, which is worth approximately $0. The most recent transaction as insider was on Aug 01, 2024, when has been sold 58,876 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Gabrielle Sulzberger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 01 2024	SELL Sale (or disposition) back to the issuer	-	58,876 Reduced 100.0%	0 Common Stock
Jun 05 2024	BUY Grant, award, or other acquisition	-	10,461 Added 15.09%	58,876 Common Stock
Jun 07 2023	BUY Grant, award, or other acquisition	-	3,282 Added 6.42%	47,853 Common Stock
Jun 24 2022	BUY Exercise of conversion of derivative security	-	14,270 Added 18.26%	63,894 Common Stock
Jun 24 2021	BUY Exercise of conversion of derivative security	-	14,270 Added 22.33%	49,624 Common Stock
Jun 17 2021	BUY Open market or private purchase	$275,357 $13.06 p/Share	21,084 Added 37.36%	35,354 Common Stock

Also insider at

Mastercard Inc Financial Services

Director

LLY

ELI LILLY & Co Healthcare

Director

BRX

Brixmor Property Group Inc. Real Estate

Director

WRBY

Warby Parker Inc. Healthcare

Director